Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing Surveillance of Optison in Routine Echocardiography
NCT00730964Phase 4Completed
- Sponsor
- GE HealthCare
- Start
- May 2008
- Primary completion
- Oct 2009
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of perflutren lipid microspheres, sponsored by GE HealthCare. Started May 2008; status: completed.
02
Drugs
perflutren lipid microspheres
Beyond the preview
Go deeper on NCT00730964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730964.